Beyond Gout: Colchicine Use in the Cardiovascular Patient
- PMID: 27729672
- PMCID: PMC5057191
- DOI: 10.1310/hpj5010-859
Beyond Gout: Colchicine Use in the Cardiovascular Patient
Abstract
Colchicine is one of the oldest medications still in use today and is commonly used for the treatment of gout and familial Mediterranean fever. Its anti-inflammatory properties have raised the question of its utility in managing several cardiovascular diseases, including postoperative atrial fibrillation and pericarditis. This article will review the evidence for colchicine in these conditions and provide recommendations for use.
References
-
- Kesselheim AS, Solomon DH. Incentives for drug development – the curious case of colchicine. N Engl J Med. 2010;362:2045–2047. - PubMed
-
- Deftereos S, Giannopoulo G, Papoutsidakis N, et al. Colchicine and the heart. J Am Coll Cardiol. 2013;62:1817–1825. - PubMed
-
- Echahidi N, Pibarot P, O’Hara G, et al. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol. 2008:51:793–801. - PubMed
-
- Imazio M, Brucato A, Ferrazzi P, et al. Colchicine reduces postoperative atrial fibrillation: Results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation. 2011;124:2290–2295. - PubMed
-
- Davis EM, Packard KA, Hilleman DE. Pharmacologic prophylaxis of postoperative atrial fibrillation in patients undergoing cardiac surgery: Beyond β-blockers. Pharmacotherapy. 2010;30:274e–318e. - PubMed
Publication types
LinkOut - more resources
Full Text Sources